NovoCure
NVCR
NVCR
310 hedge funds and large institutions have $5.94B invested in NovoCure in 2021 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 124 increasing their positions, 91 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
7% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 61
2% less funds holding
Funds holding: 316 → 310 (-6)
34% less capital invested
Capital invested by funds: $9.01B → $5.94B (-$3.08B)
Holders
310
Holding in Top 10
2
Calls
$124M
Puts
$119M
Top Buyers
| 1 | +$58.2M | |
| 2 | +$22.5M | |
| 3 | +$21.5M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$18.4M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$15.5M |
Top Sellers
| 1 | -$35.4M | |
| 2 | -$33.1M | |
| 3 | -$20.1M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$15.9M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$12.6M |